Ultragenyx (RARE) Reports Q4 Loss, Tops Revenue Estimates
Portfolio Pulse from
Ultragenyx (RARE) reported a Q4 loss of $1.39 per share, which was larger than the Zacks Consensus Estimate of a $1.24 loss. However, the company exceeded revenue expectations.
February 13, 2025 | 11:30 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Ultragenyx reported a Q4 loss of $1.39 per share, missing the Zacks estimate of $1.24. Despite the larger loss, the company exceeded revenue expectations, which may mitigate negative sentiment.
The larger-than-expected loss per share could negatively impact the stock price. However, surpassing revenue expectations may offset some of the negative sentiment, leading to a neutral short-term impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100